Andrea Rubbert‐Roth

机构：University of Zurich, Kantonsspital St. Gallen, University Hospital Zurich · ORCID：0000-0002-9016-2833

发表论文 232 篇 · 总被引 21313 次 · h-index 48

代表论文

• A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis (2025 · New England Journal of Medicine · 被引 99)
• Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study (2024 · RMD Open · 被引 13)
• LBA0001 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH GIANT CELL ARTERITIS (SELECT-GCA): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL (2024 · Annals of the Rheumatic Diseases · 被引 13)
• Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study (2024 · Rheumatology and Therapy · 被引 12)
• Anti-CD74 autoantibodies in axial spondyloarthritis as biomarkers for activity and severity of disease but not for tumour necrosis factor inhibitor retention: data from the Swiss Clinical Quality Management in rheumatic diseases cohort (2025 · Clinical Rheumatology · 被引 6)
• Secukinumab for Giant Cell Arteritis (2026 · NEJM Evidence · 被引 4)